[Preparative isolation and some properties of SV40 T-antigen]. 1977

O B Driza, and A D Voskoboinik, and A V Polotskaia, and M A Shliankevich, and V S Shapot

SV40 T-antigen was isolated from hamster tumors and purified about 1600-fold by the procedure including successive ammonium sulfate precipitation, chromatography on DEAE-cellulose, preparative polyacrylamide gel electrophoresis and elimination of the bulk of contaminating cell proteins by the interaction with antibodies to the tissues of normal hamsters. The resulting preparation was not quite homogenous being contaminated with some of cell proteins left. T-antigen in the tumor extract was revealed at least in three distinct forms with molecular weight of 100 000, 200 000, and 400 000. It is proposed that these forms correspond to mono-, di-, and tetramers of the basal protein of T-antigen, although the alternative explanation, the existence of complex of T-antigen with cell proteins, cannot be ruled out.

UI MeSH Term Description Entries
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D013539 Simian virus 40 A species of POLYOMAVIRUS originally isolated from Rhesus monkey kidney tissue. It produces malignancy in human and newborn hamster kidney cell cultures. SV40 Virus,Vacuolating Agent,Polyomavirus macacae,SV 40 Virus,SV 40 Viruses,SV40 Viruses,Vacuolating Agents
D046911 Macromolecular Substances Compounds and molecular complexes that consist of very large numbers of atoms and are generally over 500 kDa in size. In biological systems macromolecular substances usually can be visualized using ELECTRON MICROSCOPY and are distinguished from ORGANELLES by the lack of a membrane structure. Macromolecular Complexes,Macromolecular Compounds,Macromolecular Compounds and Complexes,Complexes, Macromolecular,Compounds, Macromolecular,Substances, Macromolecular

Related Publications

O B Driza, and A D Voskoboinik, and A V Polotskaia, and M A Shliankevich, and V S Shapot
January 1975, Cold Spring Harbor symposia on quantitative biology,
O B Driza, and A D Voskoboinik, and A V Polotskaia, and M A Shliankevich, and V S Shapot
January 1980, Cold Spring Harbor symposia on quantitative biology,
O B Driza, and A D Voskoboinik, and A V Polotskaia, and M A Shliankevich, and V S Shapot
January 1967, Israel journal of medical sciences,
O B Driza, and A D Voskoboinik, and A V Polotskaia, and M A Shliankevich, and V S Shapot
August 1986, Virology,
O B Driza, and A D Voskoboinik, and A V Polotskaia, and M A Shliankevich, and V S Shapot
November 1965, Virology,
O B Driza, and A D Voskoboinik, and A V Polotskaia, and M A Shliankevich, and V S Shapot
January 1989, Immunogenetics,
O B Driza, and A D Voskoboinik, and A V Polotskaia, and M A Shliankevich, and V S Shapot
January 1988, Immunogenetics,
O B Driza, and A D Voskoboinik, and A V Polotskaia, and M A Shliankevich, and V S Shapot
February 1993, Virology,
O B Driza, and A D Voskoboinik, and A V Polotskaia, and M A Shliankevich, and V S Shapot
January 1987, Cell,
O B Driza, and A D Voskoboinik, and A V Polotskaia, and M A Shliankevich, and V S Shapot
January 1972, Archiv fur die gesamte Virusforschung,
Copied contents to your clipboard!